Search research articles
Contact Us
Filters
Showing results (381-390 of 403) with videos related to
Page
of 41
Sort By:
Current Cancer Drug Targets
|
June 29, 2010
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases
M Salerno, E Cenni, C Fotia, et al.
Viruses
|
November 17, 2015
Meningitis Caused by Toscana Virus Is Associated with Strong Antiviral Response in the CNS and Altered Frequency of Blood Antigen-Presenting Cells
Stefania Varani, Francesco Gelsomino, Michele Bartoletti, et al.
European Journal of Cell Biology
|
April 30, 2025
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma
Maria Vittoria Marvi, Camilla Evangelisti, Camilla Bruna Cerchier, et al.
Internal and Emergency Medicine
|
March 16, 2020
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study
Elisa Ricciardi, Giovanni La Malfa, Giulia Guglielmi, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
International Journal of Environmental Research and Public Health
|
February 11, 2023
Formaldehyde and Acetaldehyde Exposure in "Non-Traditional" Occupational Sectors: Bakeries and Pastry Producers
Lucia Miligi, Sara Piro, Chiara Airoldi, et al.
Aging Cell
|
January 4, 2021
Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice
Stefano Squarzoni, Elisa Schena, Patrizia Sabatelli, et al.
Annals of the Rheumatic Diseases
|
November 6, 2023
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, et al.
Journal of Medicinal Chemistry
|
February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
Daniela Angst, François Gessier, Philipp Janser, et al.
Trials
|
October 5, 2012
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial
Paolo Zamboni, Antonio Bertolotto, Paolo Boldrini, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 403) with videos related to
Sort By:
Page
of 41
Current Cancer Drug Targets
|
June 29, 2010
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases
M Salerno, E Cenni, C Fotia, et al.
Viruses
|
November 17, 2015
Meningitis Caused by Toscana Virus Is Associated with Strong Antiviral Response in the CNS and Altered Frequency of Blood Antigen-Presenting Cells
Stefania Varani, Francesco Gelsomino, Michele Bartoletti, et al.
European Journal of Cell Biology
|
April 30, 2025
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma
Maria Vittoria Marvi, Camilla Evangelisti, Camilla Bruna Cerchier, et al.
Internal and Emergency Medicine
|
March 16, 2020
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study
Elisa Ricciardi, Giovanni La Malfa, Giulia Guglielmi, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
International Journal of Environmental Research and Public Health
|
February 11, 2023
Formaldehyde and Acetaldehyde Exposure in "Non-Traditional" Occupational Sectors: Bakeries and Pastry Producers
Lucia Miligi, Sara Piro, Chiara Airoldi, et al.
Aging Cell
|
January 4, 2021
Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice
Stefano Squarzoni, Elisa Schena, Patrizia Sabatelli, et al.
Annals of the Rheumatic Diseases
|
November 6, 2023
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, et al.
Journal of Medicinal Chemistry
|
February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
Daniela Angst, François Gessier, Philipp Janser, et al.
Trials
|
October 5, 2012
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial
Paolo Zamboni, Antonio Bertolotto, Paolo Boldrini, et al.
Page
of 41